Tennor Therapeutics Limited

Room 711, Floor B2, Shengwu Nami Park, No.218, Xinghu Street, Suzhou Industrial Park, Suzh oupian District, China Pilot Free Trade Zone, Suzhou, 江苏省, China

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

66.7%

Phase 2

33.3%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (3)

Absorption, Metabolism, and Excretion Study of [14C]-TNP-2092

Phase 1

Completed

interventional

Oct 20216 participants

Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty

Phase 1

Completed

interventional

Mar 202113 participants

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Phase 2

Completed

interventional

Apr 2019120 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations